Viking Global Investors LP Royalty Pharma PLC Transaction History

Viking Global Investors LP

$29.9 Billion
Q1 2025

A detailed history of Viking Global Investors LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Viking Global Investors LP holds 10,563,939 shares of RPRX stock, worth $377 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

10,563,939

Previous 12,207,885 13.47%

Holding current value

$377 Million

Previous $311 Million 5.6%

% of portfolio

1.1%

Previous 1.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $42.3 Million - $55.7 Million	-1,643,946 Reduced 13.47%	10,563,939 $329 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $2.76 Million - $3.23 Million	113,864 Added 0.94%	12,207,885 $311 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $3.18 Million - $3.63 Million	123,963 Added 1.04%	12,094,021 $342 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $12.7 Million - $14.5 Million	484,511 Added 4.22%	11,970,058 $316 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $38.4 Million - $43.8 Million	1,398,130 Added 13.86%	11,485,547 $349 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $16.3 Million - $18.2 Million	623,216 Added 6.58%	10,087,417 $283 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $10.2 Million - $12.1 Million	-386,731 Reduced 3.93%	9,464,201 $257 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $40.1 Million - $49.5 Million	-1,353,317 Reduced 12.08%	9,850,932 $303 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $39.2 Million - $47.1 Million	1,195,738 Added 11.95%	11,204,249 $404 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $34.2 Million - $38.5 Million	-873,083 Reduced 8.02%	10,008,511 $396 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $59.4 Million - $66.5 Million	-1,489,100 Reduced 12.04%	10,881,594 $437 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $60.3 Million - $71 Million	1,606,222 Added 14.92%	12,370,694 $520 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $16.8 Million - $19.1 Million	449,094 Added 4.35%	10,764,472 $419 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $217 Million - $262 Million	6,174,870 Added 149.13%	10,315,378 $411 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $32.6 Million - $38.1 Million	901,854 Added 27.85%	4,140,508 $150 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $46.9 Million - $54.9 Million	1,176,901 Added 57.08%	3,238,654 $133 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $9.54 Million - $11.9 Million	-225,247 Reduced 9.85%	2,061,753 $89.9 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $12.2 Million - $17 Million	338,936 Added 17.4%	2,287,000 $114 Million
Q3 2020 Nov 16, 2020	SELL	$38.56 - $48.36 $21.9 Million - $27.4 Million	-566,921 Reduced 22.54%	1,948,064 $82 Million
Q2 2020 Aug 07, 2020	BUY	$44.5 - $52.11 $112 Million - $131 Million	2,514,985 New	2,514,985 $122 Million

Others Institutions Holding RPRX

# of Institutions

486

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Account

Viking Global Investors LP Royalty Pharma PLC Transaction History